39 Dungan et al analyzed data from PIONEER trials and found out that the proportion of patients achieving clinically relevant reductions in both HbA1c and body mass were significantly greater in the group treated with orally administered semaglutide versus comparators (liraglutide, empagliflozin, sitagliptin)
A well-matched GLP-1 helps: Reduce appetite steadily, not suddenly Lower post-meal sugar spikes, which drive fat storage Improve satiety and help you feel full of smaller meals
Benchmarking Analysis, 2025 17.5
However, the glucuronidation pathway is not upregulated by repeated exposure to APAP [71] and is a minor pathway in babies and children, as discussed above [63,64]
Zhonghua Yi Xue Za Zhi 2017, 97, 131136
More impressive: 91% of those on 15mg lost at least 5% of their starting weight, and 57% crossed the 20% threshold